Ginsenoside Re Attenuates High Glucose-Induced RF/6A Injury via Regulating PI3K/AKT Inhibited HIF-1α/VEGF Signaling Pathway
Author:
Publisher
Frontiers Media SA
Subject
Pharmacology (medical),Pharmacology
Reference45 articles.
1. Diabetic Retinopathy and Other Ocular Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study;Aiello;Diabetes Care,2014
2. Global prevalence and causes of visual impairment with special reference to the general population of Saudi Arabia;Alswailmi;Pak. J. Med. Sci.,2018
3. Vascular Complications of Diabetes;Beckman;Circ. Res.,2016
4. Current approaches to the management of diabetic retinopathy and diabetic macular oedema;Boscia;Drugs,2010
5. MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1α/HIF-1β;Cao;Mol. Cancer,2010
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Transthyretin-Regulated Diabetic Retinopathy Through the VEGFA/PI3K/AKT Pathway;Investigative Opthalmology & Visual Science;2024-01-30
2. Chanling Gao suppresses colorectal cancer via PI3K/Akt/mTOR pathway modulation and enhances quality of survival;Environmental Toxicology;2023-10-12
3. miR-410 Regulates Helper T Cell Differentiation in Ovalbumin-Induced Asthma through the PI3K-AKT-VEGF Signaling Pathway;International Archives of Allergy and Immunology;2023-09-19
4. Ginsenosides for therapeutically targeting inflammation through modulation of oxidative stress;International Immunopharmacology;2023-08
5. Ginsenoside Rg3 has effects comparable to those of ginsenoside re on diabetic kidney disease prevention in db/db mice by regulating inflammation, fibrosis and PPARγ;Molecular Medicine Reports;2023-03-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3